Twitter | Search | |
Search Refresh
Francis S. Collins 30 Aug 17
New hope for kids and young adults with acute : approves therapy.
Reply Retweet Like
Rosha Poudyal 30 Aug 17
Reply Retweet Like
The Children's Inn 31 Aug 17
Exciting progress made for our residents battling
Reply Retweet Like
John Barnes ⚽🚘 Jul 20
My brother Kev smashing it with Snods after the transplant last year 👊🏼👊🏼💙
Reply Retweet Like
Rare Diseases Sep 25
BLINCYTO® () Approved In For The Treatment Of Relapsed Or Refractory B-cell Acute — CheckOrphan
Reply Retweet Like
Tornos News 15 Aug 17
Reply Retweet Like
Drug Topics 9 Dec 14
to treat approved, carries boxed warning
Reply Retweet Like
John Barnes ⚽🚘 17 Aug 17
Replying to @johnsonian09
Big thanks Johno! Us Barneys will smash it! 💙👊🙌🏻🙌🏻
Reply Retweet Like
Dalmunzie Castle 5 May 16
Tx of older pts with relapsed/refractory B-precursor acute by
Reply Retweet Like
GenPath Oncology 28 Jan 16
For cases when it’s difficult to differentiate from , our panels can make it easier
Reply Retweet Like
Jimmy Li 16 Oct 14
Scientists have found a potential treatment for using the patients' own T-cells
Reply Retweet Like
EmbaMex IRN 31 Jul 14
In re acute , the main type of cancer affecting children, out of 1533 cases has achieved 84% survival...
Reply Retweet Like
Viglya Oct 3
authorizes first next generation sequencing-based test to detect very low levels of remaining cells in with acute or
Reply Retweet Like
المستشفى السعودي الألماني جدة 21 Aug 17
The U.S. approved the anti-cancer drug to treat B-cell acute
Reply Retweet Like
Noelly✨ 21 Apr 15
Reply Retweet Like
Cancer Fighting Club 31 Aug 17
-T uses patients’ + rewires them to kill . for
Reply Retweet Like
PhiladelphiaUnquirer 20 Jan 15
The Inventor Of Instant Replay, Tony Verna, ...
Reply Retweet Like
Beacon Intelligence Oct 1
FDA gives green light to assay and authorizes 1st next generation sequencing-based test for minimal cancer cells remaining in patients with acute or . This means more sensitive and accurate readouts!
Reply Retweet Like
Your RxSpark Apr 6
The FDA has approved Blincyto as a treatment to reduce the risk of relapse in certain patients with B-cell precursors acute lymphoblastic leukemia (ALL).
Reply Retweet Like
Viglya 8 Dec 14
Reply Retweet Like